ClearPoint Neuro CLPT
NASDAQ CLPT
$15.39 +0.20 (+1.32%)
At close: Aug 21, 2026 · 4:00 PM EDT

ClearPoint Neuro (CLPT) Change in Acquisitions & Divestments (2022)

ClearPoint Neuro (CLPT) posted Change in Acquisitions & Divestments of $12.0 million for Q4 2022.

ClearPoint Neuro (CLPT) Change in Acquisitions & Divestments (2022) Analysis & Trends

ClearPoint Neuro has reported Change in Acquisitions & Divestments for 1 years, with the latest figure at $12.0 million in Q4 2022.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $12.0 million in Q4 2022, while the trailing twelve-month figure through Sep 2024 was $12.0 million (changed N/A YoY) and the FY2023 annual result came in at $10.0 million, down 16.67% from the prior year.
  • Change in Acquisitions & Divestments was little changed at $12.0 million in Q4 2022 per CLPT's latest filing.
  • Over five years, Change in Acquisitions & Divestments peaked at $12.0 million in Q4 2022 and troughed at $12.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 ClearPoint Neuro 464.87 Mn 435.47 Mn 6.71 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 12.00 Mn
Dec 31, 2022 12.00 Mn